Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
AI Algorithms Fuel Surge in Insurance Claim Denials, Dentists Say
Insurance carriers are increasingly relying on AI to process and deny claims, a trend that dentists say is tightening cash flow and obscuring accountability. Founder Jordon Comstock of BoomCloud warns that the lack of transparency is forcing many practices to explore direct‑patient membership models.
Advancing Generic Drug Development: Bioequivalence Challenges for Patient-Centric Oral Formulations - 06/11/2026
The FDA’s Center for Drug Evaluation and Research hosted a two‑day workshop on June 11, 2026 to address bioequivalence challenges in patient‑centric oral generic drugs, including pediatric formulations. Experts discussed development hurdles for chewable tablets, orally disintegrating tablets, granules, suspensions, and sublingual...
MercyOne to Shut Southside Des Moines Clinic Amid Pending Medicaid Cuts
MercyOne announced the closure of its southside Des Moines clinic next month, blaming staffing gaps, soaring operating expenses and pending Medicaid reimbursement reductions. Advocates warn the shutdown will strip low‑income Iowans of essential care, especially children who rely heavily on...
Diuretic Resistance Score Confirms TRANSFORM-HF’s Message
A post‑hoc analysis of the TRANSFORM‑HF trial applied the BAN‑ADHF risk score to identify patients at high risk of diuretic resistance. About 21% of the 2,421 participants scored above 12, indicating a markedly worse prognosis with 79% higher mortality and...
Skyports Launches Daily Drone Delivery Across NYC’s East River for Medical Supplies
British firm Skyports has started daily weekday drone trips across New York City’s East River, ferrying light medical paperwork for an unnamed health‑care system. The pilot, run by the Port Authority of New York and New Jersey and the NYC Economic...
ASNC Speaks to Policymakers About Prior Authorization, Medicare Cuts and More
During its second annual Hill Day, the American Society of Nuclear Cardiology (ASNC) convened 19 advocates who met with 66 congressional offices to discuss key policy issues. The society backed the bipartisan Improving Seniors’ Timely Access to Care Act to...
Sarasota Memorial IDs Lung Cancers Earlier with Analytics Platform
Sarasota Memorial Health Care System adopted the Eon analytics platform to scan radiology reports, surface incidental lung nodules, and manage patient follow‑up. The solution lifted real‑time alerts from 1‑2 per week to roughly 170, enabling a dedicated lung nodule clinic....
Book Excerpt: "Through the Fire: How People with Mental Illness Are Empowering Each Other"
An estimated 380,000 Americans with serious mental illness (SMI) are behind bars, a figure ten times higher than the population in state psychiatric hospitals. The excerpt highlights the case of Jamie Lee Wallace, whose suicide after testifying about Alabama’s neglectful...
European Regulators Approve First‑In‑Human GLP‑1 Gene Therapy Trial for Fractyl Health
Fractyl Health received European regulatory approval to begin the first human trial of its GLP‑1 gene therapy, a novel approach that could replace chronic GLP‑1 injections. The clearance marks the inaugural clinical test of this gene‑editing strategy in Europe and...
ThoroughCare Expands Remote Patient Monitoring with Withings Integration
ThoroughCare announced a partnership with Withings Health Solutions to embed Withings cellular smart scales directly into its care coordination platform. The plug‑and‑play devices automatically transmit weight readings without Wi‑Fi or Bluetooth pairing, giving clinicians real‑time data. The integration supports Remote...
In the Clinic for May 11, 2026
BioWorld’s May 11, 2026 “In the Clinic” roundup aggregates the day’s most relevant biopharma and med‑tech snapshots, special reports, and infographics. The page links to data‑driven analyses covering topics from mRNA vaccine research and China’s GLP‑1 landscape to pulsed‑field ablation for atrial...
Integration Costs Shift to RPA as APIs Become Liabilities
Software ships at near-zero marginal cost. The maintenance tail does not. Every API is a liability the moment it ships, and a finite R&D budget can only service so much of yesterday's surface area before next quarter's earnings call wins...
GE HealthCare Showcases AI-Powered MRI Technologies
At the ISMRM 2026 meeting, GE HealthCare announced a suite of AI‑powered MRI innovations designed to speed scans, improve image quality and support collaborative research. The rollout includes the SIGNA One workflow platform, Sonic DL deep‑learning acceleration pending FDA clearance,...
Turning Postpartum Skepticism Into Women’s Health Unicorn
Imagine pitching the company that would eventually become the first unicorn in women’s health, only to have investors laugh in your face at the word "postpartum". On the latest Lifers, @_KateRyder and I go deep on what it actually...
End Preventable Maternal Deaths: Support Moms Year‑round
After the brunch and flowers, we need to show up for moms the rest of the year by finally taking on preventable maternal deaths. #HealthyMomsHealthyBabiesAmerica https://t.co/njB28BAINh
‘The System Is Broken’: Dermatology’s Rural Workforce Needs Rebuilding
Dermatology is heavily concentrated in urban centers, leaving rural America underserved despite one‑in‑five Americans living outside cities. A recent study identified 11,656 dermatologists across 13,774 sites, with only 11% of physicians practicing in rural areas, creating long wait times and...
LQDA’s Soaring Market Share Proves Drug Superiority
$LQDA "Market share has gone from 10% to 16% to 23% across past 3 quarters" That doesn't happen against an entrenched competitor unless the drug is truly better.
An Ancient Hibernation Switch Lives in Your DNA—And Scientists Are Tapping Into Its Power
Scientists have identified ancient cis‑regulatory DNA switches that enable hibernating mammals to shut down and restart metabolism safely, and they found the same genetic circuitry embedded in the human genome. The finding comes from two new studies published in Science...
Job Opportunities: 5.11.26
The blog post shares a curated list of 50 public‑health‑related job openings across the United States, ranging from senior consulting roles at Guidehouse to analyst positions at state health departments and research jobs at universities. Salaries span roughly $50k to...
New Home for Novo's Parkinson's Cell Therapy; GSK's Deal to Sell Drug in China
Novo Nordisk has transferred its early‑stage Parkinson's disease cell therapy to a specialized biotech partner, allowing the pharma giant to offload development risk while retaining royalty rights. GSK secured a distribution agreement to launch its flagship drug in China, opening...
Medtronic to Close California Site Amid Restructuring
Medtronic announced it will shut its Santa Rosa, California, facility within the next two years, targeting a spring 2028 closure. The decision follows a global operations review and coincides with the creation of a new cardiovascular‑surgery unit that merges its...
Ibasho Concept Offers a Community-Led Approach to Disaster Psychiatry
A recent Lancet correspondence by Juntendo University researchers proposes the Japanese "ibasho" concept as a community‑led approach to post‑disaster mental health. Ibasho refers to locally anchored spaces that restore belonging, routines, and meaningful roles, complementing traditional acute symptom screening. The...
GLP‑1 Drugs Boost Survival, Cut Recurrence in Obese Breast Cancer Patients
In women with breast cancer and obesity or T2 diabetes, a large propensity matching retrospective analysis reports association of GLP-1 drug therapy with improved survival and reduced risk of recurrence https://t.co/GjimCr97S0
CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia
CEL‑SCI Corp. has signed a strategic partnership with Saudi firm Amarox to register, commercialize, and distribute its immunotherapy Multikine in Saudi Arabia, with a 50/50 revenue‑sharing model. Amarox will act as the local regulatory representative, seeking the Saudi Food and...
Telehealth Didn’t Break the Bank—And the Data Prove It
A UCLA‑led analysis of 3.04 million insured adults from 2019‑2023 found that the telemedicine surge did not drive higher ambulatory visits or total medical spending, which totaled $178.44 billion. High‑adoption regions saw a 2.4% dip in visits and a 0.5% dip in...
No Link Between PCOS and Higher Rate of Abnormal Cysts: Study
A new JAMA Internal Medicine study of 1,235 Finnish women found that polycystic ovary syndrome (PCOS) does not increase the prevalence of abnormal, non‑cancerous ovarian cysts compared with women without the condition. While PCOS patients were 12‑times more likely to...
OM1 Supports 650,000 Patient Real-World Regulatory Submission for FDA Approval of Hologic’s Aptima HPV Assay
OM1’s AI‑driven real‑world evidence platform underpinned a landmark FDA submission that cleared Hologic’s Aptima HPV assay for primary cervical cancer screening. The study aggregated data from more than 650,000 women across U.S. health systems, automating extraction from electronic health records...
Health Info Net Advances Sovereign Digital Healthcare With Red Hat and VSHN
Health Info Net (HIN) partnered with Red Hat and managed‑service provider VSHN to migrate its IT services to a multivendor private‑cloud built on Red Hat OpenShift. The new sovereign infrastructure, spanning Swiss clouds Cloudscale and Exoscale, was stood up in 36 hours and...
Iambic to Participate in Upcoming Investor Conferences
Iambic, a clinical‑stage life‑science firm that uses AI to discover medicines, announced its participation in three high‑profile investor events: the Bank of America Healthcare Conference (May 12‑14), the Jefferies Global Healthcare Conference (June 2‑4) and the Bank of America Technology Conference (June 2‑4)....
Avenacy Announces Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection in the U.S. Market
Avenacy, a specialty injectable drug company, has launched a ready‑to‑use Tranexamic Acid 0.7% Sodium Chloride Injection in the United States. The product mirrors the active ingredient of Pfizer’s CYKLOKAPRON® and is indicated for short‑term use in hemophilia patients undergoing tooth...
Health Info Net Advances Sovereign Digital Healthcare With Red Hat and VSHN
Health Info Net (HIN) partnered with Red Hat and managed‑service provider VSHN to build a sovereign, cloud‑native platform on Red Hat OpenShift. The migration moved HIN from static servers to a multivendor private cloud spanning Swiss providers Cloudscale and Exoscale, completing the...
Media Advisory: Surescripts to Highlight Smarter Health Intelligence Sharing That Helps Close Gaps in Patient Care at AHIP 2026
Surescripts, the leading health intelligence network, will speak at AHIP 2026 in Las Vegas about using smarter data sharing to close care gaps. Interoperability experts Justin McMartin and Matt Hartzler will detail how linking health‑plan data with pharmacy‑fill and clinical records can pinpoint adherence...
The Hidden Design Flaw in Medical Device Service Technology
Medical device service platforms still rely on industrial‑style metrics such as uptime and ticket closure, which ignore the regulatory and safety dimensions of clinical equipment. In regulated health settings, a device must be demonstrably ready for patient use, with real‑time...
DR Multiplies Risks for Glaucoma, Ocular Hypertension
A new retrospective analysis of 5.7 million U.S. patients shows diabetic retinopathy (DR) dramatically increases the risk of glaucoma and ocular hypertension. In type 1 diabetes, DR raises glaucoma risk by roughly 5‑fold and ocular hypertension risk by nearly 5‑fold; in type 2...
Inhibrx Says Combo Therapy Shrank More Tumors than Merck's Keytruda Alone
San Diego‑based biotech Inhibrx reported that its experimental antibody INBRX‑106, when paired with Merck’s immunotherapy Keytruda, produced a higher rate of tumor shrinkage than Keytruda alone in patients with metastatic head and neck squamous cell carcinoma. The early‑stage study enrolled...
Therorna to Showcase Clinical-Ready Circular RNA in Vivo CAR-T and CircRNA Pipeline at the 2026 American Society of Gene &...
Therorna Inc. will present three posters at the 2026 ASGCT meeting, highlighting its lead in‑vivo CAR‑T candidate TI‑0032, a circRNA‑encoded CD19×CD3 T‑cell engager, and the HPV16 therapeutic vaccine TI‑0093. TI‑0032 has just entered a first‑in‑human investigator‑initiated trial for refractory autoimmune...
Internal Nanobodies Tackle Cystic Fibrosis
Researchers have engineered a cell‑penetrating nanobody that enters airway cells and stabilizes the misfolded CFTR protein responsible for cystic fibrosis. By fusing the nanobody to a ten‑arginine peptide, the hybrid molecule crosses the cell membrane and restores up to 90%...
Quantum Health Adds Prescription Cost Guidance Through Scripta Integration
Quantum Health partnered with Scripta Insights to embed prescription‑savings guidance into its care‑coordination platform. The integration surfaces lower‑cost, clinically equivalent drug alternatives, supports member‑prescriber engagement, and delivers analytics across existing PBM contracts. By extending its navigation model to pharmacy benefits,...
An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
For six decades the ventriculoperitoneal shunt has been the standard treatment for hydrocephalus, but its invasive nature and high complication rates limit patient eligibility. Endovascular neurosurgery, refined through stroke and aneurysm care, now enables catheter‑based shunt placement that avoids craniotomy....
Medical Device Regulator Seeks Stakeholder Views on New Premarket Requirements
UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has opened a stakeholder impact survey on its draft Medical Devices (Amendment) Regulations 2026, which propose new pre‑market requirements for medical devices and in‑vitro diagnostics. The consultation, published on the WTO notification...
The Benefits of Molecular Testing in Acute Gastroenteritis Diagnosis
Acute gastroenteritis remains a leading global health burden, causing over one million deaths in 2021 and driving more than 770,000 hospital discharges annually in Europe. Bacterial pathogens such as Campylobacter, Salmonella and STEC dominate cases, while rapid, accurate diagnosis is...
How MFN Impacts Drug Development and Launch Planning
President Trump’s Most Favored Nation (MFN) drug‑pricing proposals, still pending congressional approval, would cap Medicaid, Medicare Part B and Part D prices at the lowest GDP‑adjusted price among a list of 20 reference nations. The rule would force pharmaceutical companies to reassess...
Ocrevus Slows Disability Progression in Advanced PPMS, Trial Finds
A Phase 3 ORATORIO‑HAND trial involving more than 1,000 adults with primary progressive multiple sclerosis (PPMS) showed that Ocrevus (ocrelizumab) significantly slows disability progression. Over a median follow‑up of nearly three years, the drug reduced the risk of confirmed disability...
GNPS2 Enables Comprehensive Drug Metabolism Toolkit
Nature Protocols: A versatile toolkit for drug metabolism studies with GNPS2: from drug development to clinical monitoring https://t.co/lEejrO6gXT https://t.co/qlybcRgD9V
New Photoacoustic Imaging Helps Robotic Surgeons Avoid Hidden Anatomical Hazards
Researchers at Worcester Polytechnic Institute have integrated photoacoustic (PA) imaging into robot‑assisted laparoscopic surgery, creating real‑time 3‑D maps of hidden blood vessels and nerves. The PA probe, introduced through a standard laparoscopic port, overlays depth‑coded images onto the endoscopic video,...
From Reactive to Predictive: How Healthcare Organizations Can Stay Ahead of Cyber Threats
In 2024 U.S. healthcare faced a record 444 ransomware and data‑theft incidents, making it the most targeted critical‑infrastructure sector. Medical records now command $1,000 per file on dark‑web markets, driving attackers to exploit legacy systems, telehealth platforms, and IoT devices....
Why Gen AI Is a Win for MedTech: And, How to Unlock Its Potential with the Right Policies
Generative AI is rapidly becoming a core productivity tool in medical device development, accelerating tasks such as code generation, unit testing and especially documentation. Studies show AI can reduce unit‑testing effort by up to 70%, while AI‑drafted design artifacts free...
5 Keys to Enhancing Automation, Expanding Capacity and Improving Efficiency to Reduce Costs
Healthcare providers face tighter margins, staffing shortages and complex payer rules in 2026, prompting a move away from reactive revenue‑cycle models. Organizations are adopting intelligent automation that targets front‑end functions such as eligibility, authorization and financial clearance, using AI‑driven decision...
Regulating Private Equity in Health Care: A Strategic Policy Agenda
Private equity has poured roughly $1 trillion into U.S. health‑care assets over the past ten years, reshaping nursing homes, hospitals, and physician groups. Existing oversight—anchored in the Hart‑Scott‑Rodino reporting framework and limited antitrust actions—has struggled to keep pace, with more than...
Health IT Leaders Eye AI, Data Sharing to Improve Affordability
Health IT leaders, convened by the Health IT Advisory Committee, highlighted data interoperability, streamlined prior authorization, and transparent AI as levers to lower healthcare costs. ONC National Coordinator Thomas Keane underscored affordability as a top priority alongside liquidity and technology evolution....